EUS in Pancreatic Tumors

Endosonography

Volumn , Issue , 2011, Pages 148-165

  Al Haddad, Mohammad ^a   DeWitt, John ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880390559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0805-9.00014-5     Document Type: Chapter

References (171)

1. Yasuda K., Mukai H., Fujimoto S., et al. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988, 34:1-8.
2. Lin J.T., Wang J.T., Wang T.H. The diagnostic value of endoscopic ultrasonography in pancreatic disorders. Taiwan Yi Xue Hui Za Zhi 1989, 88:483-487.
3. Rosch T., Lorenz R., Braig C., et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991, 37:347-352.
4. Rosch T., Braig C., Gain T., et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992, 102:188-199.
5. Snady H., Cooperman A., Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc 1992, 38:27-34.
6. Palazzo L., Roseau G., Gayet B., et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma: results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993, 25:143-150.
7. Muller M.F., Meyenberger C., Bertschinger P., et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994, 190:745-751.
8. Marty O., Aubertin J.M., Bouillot J.L., et al. [Prospective comparison of ultrasound endoscopy and computed tomography in the assessment of locoregional invasiveness of malignant ampullar and pancreatic tumors verified surgically]. Gastroenterol Clin Biol 1995, 19:197-203.
9. Melzer E., Avidan B., Heyman Z., et al. Preoperative assessment of blood vessel involvement in patients with pancreatic cancer. Isr J Med Sci 1996, 32:1086-1088.
10. Dufour B., Zins M., Vilgrain V., et al. [Comparison between spiral x-ray computed tomography and endosonography in the diagnosis and staging of adenocarcinoma of the pancreas: clinical preliminary study]. Gastroenterol Clin Biol 1997, 21:124-130.
11. Howard T.J., Chin A.C., Streib E.W., et al. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 1997, 174:237-241.
12. Sugiyama M., Hagi H., Atomi Y., Saito M. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging 1997, 22:434-438.
13. Legmann P., Vignaux O., Dousset B., et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998, 170:1315-1322.
14. Akahoshi K., Chijiiwa Y., Nakano I., et al. Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. Br J Radiol 1998, 71:492-496.
15. Harrison J.L., Millikan K.W., Prinz R.A., Zaidi S. Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. Am Surg 1999, 65:659-664. discussion 664-655.
16. Gress F.G., Hawes R.H., Savides T.J., et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999, 50:786-791.
17. Midwinter M.J., Beveridge C.J., Wilsdon J.B., et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999, 86:189-193.
18. Mertz H.R., Sechopoulos P., Delbeke D., Leach S.D. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000, 52:367-371.
19. Rivadeneira D.E., Pochapin M., Grobmyer S.R., et al. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann Surg Oncol 2003, 10:890-897.
20. Ainsworth A.P., Rafaelsen S.R., Wamberg P.A., et al. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography?. Endoscopy 2003, 35:1029-1032.
21. Agarwal B., Abu-Hamda E., Molke K.L., et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004, 99:844-850.
22. DeWitt J., Devereaux B., Chriswell M., et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004, 141:753-763.
23. Fisher L., Segarajasingam D.S., Stewart C., et al. Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: performance and outcomes. J Gastroenterol Hepatol 2009, 24:90-96.
24. Rafique A., Freeman S., Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin Radiol 2007, 62:1142-1153.
25. Prokesch R.W., Schima W., Chow L.C., Jeffrey R.B. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol 2003, 13:2147-2154.
26. Bronstein Y.L., Loyer E.M., Kaur H., et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 2004, 182:619-623.
27. Catanzaro A., Richardson S., Veloso H., et al. Long-term follow-up of patients with clinically indeterminate suspicion of pancreatic cancer and normal EUS. Gastrointest Endosc 2003, 58:836-840.
28. Brentnall T.A., Bronner M.P., Byrd D.R., et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999, 131:247-255.
29. Rulyak S.J., Kimmey M.B., Veenstra D.L., Brentnall T.A. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003, 57:23-29.
30. Canto M.I., Goggins M., Yeo C.J., et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004, 2:606-621.
31. Langer P., Kann P.H., Fendrich V., et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 2009, 58:1410-1418.
32. Poley J.W., Kluijt I., Gouma D.J., et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009, 104:2175-2181.
33. Farrell J.J., Garber J., Sahani D., Brugge W.R. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004, 60:927-936.
34. Raina A., Yadav D., Krasinskas A.M., et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009, 104:2295-2306.
35. Hoki N., Mizuno N., Sawaki A., et al. Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 2009, 44:154-159.
36. Levy M.J., Reddy R.P., Wiersema M.J., et al. EUS-guided Trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc 2005, 61:467-472.
37. Khashab M., Mokadem M., DeWitt J., et al. Endoscopic ultrasound-guided fine-needle aspiration with or without flow cytometry for the diagnosis of primary pancreatic lymphoma: a case series. Endoscopy 2010, 42:228-231.
38. Dietrich C.F., Ignee A., Braden B., et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008, 6:590-597.
39. Becker D., Strobel D., Bernatik T., Hahn E.G. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001, 53:784-789.
40. Hocke M., Schulze E., Gottschalk P., et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006, 12:246-250.
41. Ahmad N.A., Lewis J.D., Siegelman E.S., et al. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 2000, 95:1926-1931.
42. Buscail L., Pages P., Berthelemy P., et al. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 1999, 50:34-40.
43. Giovannini M., Seitz J.F. Endoscopic ultrasonography with a linear-type echoendoscope in the evaluation of 94 patients with pancreatobiliary disease. Endoscopy 1994, 26:579-585.
44. Grimm H., Maydeo A., Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990, 4:869-888.
45. Mukai H., Nakajima M., Yasuda K., et al. [Preoperative diagnosis and staging of pancreatic cancer by endoscopic ultrasonography (EUS): a comparative study with other diagnostic tools]. Nippon Shokakibyo Gakkai Zasshi 1991, 88:2132-2142.
46. Ramsay D., Marshall M., Song S., et al. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging. Australas Radiol 2004, 48:154-161.
47. Rosch T., Dittler H.J., Lorenz R., et al. [The endosonographic staging of pancreatic carcinoma]. Dtsch Med Wochenschr 1992, 117:563-569.
48. Soriano A., Castells A., Ayuso C., et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004, 99:492-501.
49. Tio T.L., Sie L.H., Kallimanis G., et al. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. Gastrointest Endosc 1996, 44:706-713.
50. Tio T.L., Tytgat G.N., Cikot R.J., et al. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990, 175:455-461.
51. Yasuda K., Mukai H., Nakajima M., Kawai K. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy 1993, 25:151-155.
52. Howard T.J., Villanustre N., Moore S.A., et al. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg 2003, 7:1089-1095.
53. Al-Haddad M., Martin J.K., Nguyen J., et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg 2007, 11:1168-1174.
54. Ahmad N.A., Lewis J.D., Ginsberg G.G., et al. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000, 52:463-468.
55. Bhutani M.S., Hawes R.H., Hoffman B.J. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997, 45:474-479.
56. Catalano M.F., Sivak M.V., Rice T., et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994, 40:442-446.
57. Nakaizumi A., Uehara H., Iishi H., et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig Dis Sci 1995, 40:696-700.
58. Cahn M., Chang K., Nguyen P., Butler J. Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer. Am J Surg 1996, 172:470-472.
59. Hahn M., Faigel D.O. Frequency of mediastinal lymph node metastases in patients undergoing EUS evaluation of pancreaticobiliary masses. Gastrointest Endosc 2001, 54:331-335.
60. Nguyen P., Feng J.C., Chang K.J. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 1999, 50:357-361.
61. tenBerge J., Hoffman B.J., Hawes R.H., et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 2002, 55:859-862.
62. Hollerbach S., Willert J., Topalidis T., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment. Endoscopy 2003, 35:743-749.
63. DeWitt J., LeBlanc J., McHenry L., et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 2003, 98:1976-1981.
64. Chang K.J., Albers C.G., Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol 1995, 90:148-150.
65. Nguyen P.T., Chang K.J. EUS in the detection of ascites and EUS-guided paracentesis. Gastrointest Endosc 2001, 54:336-339.
66. DeWitt J., Yu M., Al-Haddad M., et al. Survival in patients with pancreatic cancer following the diagnosis of malignant ascites or liver metastases by EUS-FNA. Gastrointest Endosc 2010, 71:260-265.
67. Furukawa H., Kosuge T., Mukai K., et al. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma: usefulness for selecting surgical procedures and predicting the outcome. Arch Surg 1998, 133:61-65.
68. Ishikawa O., Ohigashi H., Sasaki Y., et al. Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreatoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998, 175:477-481.
69. Tierney W.M., Francis I.R., Eckhauser F., et al. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc 2001, 53:182-188.
70. Brugge W.R., Lee M.J., Kelsey P.B., et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 1996, 43:561-567.
71. Rosch T., Dittler H.J., Strobel K., et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 2000, 52:469-477.
72. Snady H., Bruckner H., Siegel J., et al. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994, 40:326-333.
73. Benassai G., Mastrorilli M., Quarto G., et al. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 2000, 73:212-218.
74. Richter A., Niedergethmann M., Sturm J.W., et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003, 27:324-329.
75. Saez A., Catala I., Brossa R., et al. Intraoperative fine needle aspiration cytology of pancreatic lesions: a study of 90 cases. Acta Cytol 1995, 39:485-488.
76. Schadt M.E., Kline T.S., Neal H.S., et al. Intraoperative pancreatic fine needle aspiration biopsy: results in 166 patients. Am Surg 1991, 57:73-75.
77. Brandt K.R., Charboneau J.W., Stephens D.H., et al. CT- and US-guided biopsy of the pancreas. Radiology 1993, 187:99-104.
78. Bret P.M., Nicolet V., Labadie M. Percutaneous fine-needle aspiration biopsy of the pancreas. Diagn Cytopathol 1986, 2:221-227.
79. Di Stasi M., Lencioni R., Solmi L., et al. Ultrasound-guided fine needle biopsy of pancreatic masses: results of a multicenter study. Am J Gastroenterol 1998, 93:1329-1333.
80. Sperti C., Pasquali C., Di Prima F., et al. Percutaneous CT-guided fine needle aspiration cytology in the differential diagnosis of pancreatic lesions. Ital J Gastroenterol 1994, 26:126-131.
81. Caturelli E., Rapaccini G.L., Anti M., Fabiano A., Fedeli G. Malignant seeding after fine-needle aspiration biopsy of the pancreas. Diagn Imaging Clin Med 1985, 54:88-91.
82. Ferrucci J.T., Wittenberg J., Margolies M.N., Carey R.W. Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology 1979, 130:345-346.
83. Smith F.P., Macdonald J.S., Schein P.S., Ornitz R.D. Cutaneous seeding of pancreatic cancer by skinny-needle aspiration biopsy. Arch Intern Med 1980, 140:855.
84. Vilmann P., Jacobsen G.K., Henriksen F.W., Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992, 38:172-173.
85. Faigel D.O., Ginsberg G.G., Bentz J.S., et al. Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 1997, 15:1439-1443.
86. Giovannini M., Seitz J.F., Monges G., et al. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy 1995, 27:171-177.
87. Wegener M., Pfaffenbach B., Adamek R.J. Endosonographically guided transduodenal and transgastral fine-needle aspiration puncture of focal pancreatic lesions. Bildgebung 1995, 62:110-115.
88. Binmoeller K.F., Thul R., Rathod V., et al. Endoscopic ultrasound-guided, 18-gauge, fine needle aspiration biopsy of the pancreas using a 2.8 mm channel convex array echoendoscope. Gastrointest Endosc 1998, 47:121-127.
89. Chang K.J., Nguyen P., Erickson R.A., et al. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997, 45:387-393.
90. Eloubeidi M.A., Chen V.K., Eltoum I.A., et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003, 98:2663-2668.
91. Fritscher-Ravens A., Schirrow L., Atay Z., et al. [Endosonographically controlled fine needle aspiration cytology: indications and results in routine diagnosis]. Z Gastroenterol 1999, 37:343-351.
92. Gress F., Gottlieb K., Sherman S., Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001, 134:459-464.
93. Gress F.G., Hawes R.H., Savides T.J., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest Endosc 1997, 45:243-250.
94. Harewood G.C., Wiersema M.J. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002, 97:1386-1391.
95. Hunerbein M., Dohmoto M., Haensch W., Schlag P.M. Endosonography-guided biopsy of mediastinal and pancreatic tumors. Endoscopy 1998, 30:32-36.
96. Raut C.P., Grau A.M., Staerkel G.A., et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003, 7:118-126. discussion 127-118.
97. Voss M., Hammel P., Molas G., et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut 2000, 46:244-249.
98. Wiersema M.J., Vilmann P., Giovannini M., et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997, 112:1087-1095.
99. Williams D.B., Sahai A.V., Aabakken L., et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999, 44:720-726.
100. Ylagan L.R., Edmundowicz S., Kasal K., et al. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer 2002, 96:362-369.
101. Bhutani M.S., Hawes R.H., Baron P.L., et al. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions. Endoscopy 1997, 29:854-858.
102. Fritscher-Ravens A., Brand L., Knofel W.T., et al. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol 2002, 97:2768-2775.
103. Schwartz D.A., Unni K.K., Levy M.J., et al. The rate of false-positive results with EUS-guided fine-needle aspiration. Gastrointest Endosc 2002, 56:868-872.
104. Mertz H., Gautam S. The learning curve for EUS-guided FNA of pancreatic cancer. Gastrointest Endosc 2004, 59:33-37.
105. Harewood G.C., Wiersema L.M., Halling A.C., et al. Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses. Gastrointest Endosc 2002, 55:669-673.
106. Eloubeidi M.A., Tamhane A., Jhala N., et al. Agreement between rapid onsite and final cytologic interpretations of EUS-guided FNA specimens: implications for the endosonographer and patient management. Am J Gastroenterol 2006, 101:2841-2847.
107. Klapman J.B., Logrono R., Dye C.E., Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003, 98:1289-1294.
108. Erickson R.A., Sayage-Rabie L., Beissner R.S. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000, 51:184-190.
109. LeBlanc J.K., Ciaccia D., Al-Assi M.T., et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004, 59:475-481.
110. Lee J.H., Stewart J., Ross W.A., et al. Blinded prospective comparison of the performance of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of the pancreas and peri-pancreatic lesions. Dig Dis Sci 2009, 54:2274-2281.
111. Siddiqui U.D., Rossi F., Rosenthal L.S., Aslanian H.R., et al. EUS-guided FNA of solid pancreatic masses: a prospective, randomized trial comparing 22-gauge and 25-gauge needles. Gastrointest Endosc 2009, 70:1093-1097.
112. Al-Haddad M., Wallace M.B., Woodward T.A., et al. The safety of fine-needle aspiration guided by endoscopic ultrasound: a prospective study. Endoscopy 2008, 40:204-208.
113. Gress F., Michael H., Gelrud D., et al. EUS-guided fine-needle aspiration of the pancreas: evaluation of pancreatitis as a complication. Gastrointest Endosc 2002, 56:864-867.
114. O'Toole D., Palazzo L., Arotcarena R., et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 2001, 53:470-474.
115. Micames C., Jowell P.S., White R., et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003, 58:690-695.
116. Qian X., Hecht J.L. Pancreatic fine needle aspiration: a comparison of computed tomographic and endoscopic ultrasonographic guidance. Acta Cytol 2003, 47:723-726.
117. Mallery J.S., Centeno B.A., Hahn P.F., et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002, 56:218-224.
118. Harewood G.C., Wiersema M.J. A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma. Am J Gastroenterol 2001, 96:2651-2656.
119. Chen V.K., Arguedas M.R., Kilgore M.L., Eloubeidi M.A. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am J Gastroenterol 2004, 99:2223-2234.
120. Levy M.J., Jondal M.L., Clain J., Wiersema M.J. Preliminary experience with an EUS-guided Trucut biopsy needle compared with EUS-guided FNA. Gastrointest Endosc 2003, 57:101-106.
121. Larghi A., Verna E.C., Stavropoulos S.N., et al. EUS-guided Trucut needle biopsies in patients with solid pancreatic masses: a prospective study. Gastrointest Endosc 2004, 59:185-190.
122. Varadarajulu S., Fraig M., Schmulewitz N., et al. Comparison of EUS-guided 19-gauge Trucut needle biopsy with EUS-guided fine-needle aspiration. Endoscopy 2004, 36:397-401.
123. Thomas T., Kaye P.V., Ragunath K., Aithal G. Efficacy, safety, and predictive factors for a positive yield of EUS-guided Trucut biopsy: a large tertiary referral center experience. Am J Gastroenterol 2009, 104:584-591.
124. Eloubeidi M.A., Mehra M., Bean S.M. EUS-guided 19-gauge Trucut needle biopsy for diagnosis of lymphoma missed by EUS-guided FNA. Gastrointest Endosc 2007, 65:937-939.
125. Itoi T., Takei K., Sofuni A., et al. Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses. Oncol Rep 2005, 13:229-234.
126. Kitoh H., Ryozawa S., Harada T., et al. Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration. J Gastroenterol 2005, 40:511-517.
127. Laurell H., Bouisson M., Berthelemy P., et al. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006, 12:3344-3351.
128. Maluf-Filho F., Kumar A., Gerhardt R., et al. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass. J Clin Gastroenterol 2007, 41:906-910.
129. Mishra G., Zhao Y., Sweeney J., et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc 2006, 63:648-654.
130. Salek C., Benesova L., Zavoral M., et al. Evaluation of clinical relevance of examining K- ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007, 13:3714-3720.
131. Tada M., Komatsu Y., Kawabe T., et al. Quantitative analysis of K- ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002, 97:2263-2270.
132. Jensen R.T., Norton J.A. Pancreatic endocrine tumors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2002, 988-1016. WB Saunders, Philadelphia. 7th ed. M. Feldman, B.F. Scharschmidt, M.H. Sleisenger (Eds.).
133. Modlin I.M., Tang L.H. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997, 112:583-590.
134. Madura J.A., Cummings O.W., Wiebke E.A., et al. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg 1997, 63:573-577. discussion 577-578.
135. Lam K.Y., Lo C.Y. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997, 23:36-42.
136. Kloppel G., Heitz P.U. Pancreatic endocrine tumors. Pathol Res Pract 1988, 183:155-168.
137. Schindl M., Kaczirek K., Kaserer K., Niederle B. Is the new classification of neuroendocrine pancreatic tumors of clinical help?. World J Surg 2000, 24:1312-1318.
138. Akerstrom G., Hellman P., Hessman O., Osmak L. Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology 2004, 80(suppl 1):62-66.
139. Azimuddin K., Chamberlain R.S. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001, 81:511-525.
140. Rosch T., Lightdale C.J., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992, 326:1721-1726.
141. Palazzo L., Roseau G., Chaussade S., et al. [Pancreatic endocrine tumors: contribution of ultrasound endoscopy in the diagnosis of localization]. Ann Chir 1993, 47:419-424.
142. Anderson M.A., Carpenter S., Thompson N.W., et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000, 95:2271-2277.
143. Ardengh J.C., Rosenbaum P., Ganc A.J., et al. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastrointest Endosc 2000, 51:552-555.
144. De Angelis C., Carucci P., Repici A., Rizzetto M. Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 1999, 10:139-150.
145. Gouya H., Vignaux O., Augui J., et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003, 181:987-992.
146. Proye C., Malvaux P., Pattou F., et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998, 124:1134-1143. discussion 1143-1134.
147. Zimmer T., Stolzel U., Bader M., et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996, 39:562-568.
148. Semelka R.C., Custodio C.M., Cem Balci N., Woosley J.T. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000, 11:141-148.
149. Van Nieuwenhove Y., Vandaele S., Op de Beeck B., Delvaux G. Neuroendocrine tumors of the pancreas. Surg Endosc 2003, 17:1658-1662.
150. Thoeni R.F., Mueller-Lisse U.G., Chan R., et al. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000, 214:483-490.
151. Gibril F., Reynolds J.C., Doppman J.L., et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 1996, 125:26-34.
152. van Eijck C.H., Lamberts S.W., Lemaire L.C., et al. The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors. Ann Surg 1996, 224:119-124.
153. Bansal R., Tierney W., Carpenter S., et al. Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 1999, 49:19-25.
154. Ardengh J.C., de Paulo G.A., Ferrari A.P. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004, 60:378-384.
155. Ginès A., Vazquez-Sequeiros E., Soria M.T., et al. Usefulness of EUS-guided fine needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors. Gastrointest Endosc 2002, 56:291-296.
156. Baker M.S., Knuth J.L., DeWitt J., et al. Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. J Gastrointest Surg 2008, 12:450-456.
157. Chang F., Vu C., Chandra A., et al. Endoscopic ultrasound-guided fine needle aspiration cytology of pancreatic neuroendocrine tumours: cytomorphological and immunocytochemical evaluation. Cytopathology 2006, 17:10-17.
158. Collins B.T., Cramer H.M. Fine-needle aspiration cytology of islet cell tumors. Diagn Cytopathol 1996, 15:37-45.
159. Kidd M., Modlin I.M., Mane S.M., et al. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease. Ann Surg 2006, 243:273-280.
160. Zografos G.N., Stathopoulou A., Mitropapas G., et al. Preoperative imaging and localization of small sized insulinoma with EUS-guided fine needle tattooing: a case report. Hormones (Athens) 2005, 4:111-116.
161. Fasanella K.E., McGrath K.M., Sanders M., et al. Pancreatic endocrine tumor EUS-guided FNA DNA microsatellite loss and mortality. Gastrointest Endosc 2009, 69:1074-1080.
162. Roland C.F., van Heerden J.A. Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet 1989, 168:345-347.
163. Nakeeb A., Lillemoe K.D., Cameron J.L. The role of pancreaticoduodenectomy for locally recurrent or metastatic carcinoma to the periampullary region. J Am Coll Surg 1995, 180:188-192.
164. Sperti C., Pasquali C., Liessi G., et al. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol 2003, 83:161-166. discussion 166.
165. Z'Graggen K., Fernandez-del Castillo C., Rattner D.W., et al. Metastases to the pancreas and their surgical extirpation. Arch Surg 1998, 133:413-417. discussion 418-419.
166. Ghavamian R., Klein K.A., Stephens D.H., et al. Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 2000, 75:581-585.
167. Faure J.P., Tuech J.J., Richer J.P., et al. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. J Urol 2001, 165:20-22.
168. Palazzo L., Borotto E., Cellier C., et al. Endosonographic features of pancreatic metastases. Gastrointest Endosc 1996, 44:433-436.
169. DeWitt J., Jowell P., Leblanc J., et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc 2005, 61:689-696.
170. Bechade D., Palazzo L., Fabre M., Algayres J.P. EUS-guided FNA of pancreatic metastasis from renal cell carcinoma. Gastrointest Endosc 2003, 58:784-788.
171. Fritscher-Ravens A., Sriram P.V., Krause C., et al. Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc 2001, 53:65-70.